PUD

(redirected from Pulmonary disease)
Also found in: Dictionary, Medical, Encyclopedia.
AcronymDefinition
PUDPublic Utility District
PUDPlanned Unit Development
PUDPeptic Ulcer Disease
PUDPulmonary Disease
PUDPublic Utilities Department (various locations)
PUDProved Undeveloped Reserves (energy production)
PUDPolyurethane Dispersion
PUDPersonal User Id
PUDPower Using Device
PUDProved Undeveloped (hydrocarbon reserves)
PUDPublic Utilities Division
PUDPick Up & Delivery
PUDPayment Upon Delivery
PUDPeeled Undeveined (shrimp)
PUDPlanned Use Development (real estate/land development )
PUDPartido de Unificación Democrática (Spanish: Democratic Unification Party)
PUDPotential Utility Density (computing)
PUDPenis Uncircumcising Device
PUDPower-Up Diagnostics (troubleshooting)
PUDPizza Underground Digest
PUDPointless Ups and Downs (hiking)
PUDPop-Up Detector
PUDPeri-Urethral Diathermy
PUDPaid-Up Dependent (insurance)
PUDPay Upon Death
PUDPaired Uranium Detectors
PUDPost-Urinary Drip
PUDParent Unit Designator
References in periodicals archive ?
Klaus Rabe, Professor of Pulmonary Medicine at the University of Kiel, Director of the Department of Pneumology at Clinic Grosshansdorf, Germany, and National Co-ordinating Investigator of the KRONOS trial, said: "The KRONOS trial demonstrated that Breztri Aerosphere provides rapid and sustained, clinically-relevant lung function improvements in patients with moderate to very severe chronic obstructive pulmonary disease. Triple-combination therapy is an increasingly important treatment option and will play a central role in helping patients manage their disease."
The combined effects of pulmonary rehabilitation and bronchial dilation drugs on patients with advanced pulmonary disease. Chin J Phys Med Rehab.
Chronic obstructive pulmonary disease (COPD) is predicted to be the third leading cause of mortality worldwide by 2020.1,2 COPD exacerbation is defined as an acute event characterised by worsening of patient's respiratory symptoms that is beyond normal day-to-day variations and leads to a change in medication.2 Acute exacerbations of COPD (AECOPD) are not only a cause of high mortality in these patients 3 but are also responsible for significant number of unscheduled hospital visits 4 and thus increased healthcare expenditure.
Disease Burden and Morbidity of Community-Acquired Pneumonia Associated with Chronic Obstructive Pulmonary Disease
'This is the first study to identify an association between childhood exposure to second-hand smoke and death from chronic obstructive pulmonary disease in middle age and beyond,' said W.
In 2016, a total of three million people died due to chronic obstructive pulmonary disease, which makes up 6% of total international deaths, he said, adding that the disease is expected to become the third-largest cause of death by 2020.
We calculated overall and annual prevalence rates with 95% CIs as the number of patients with [greater than or equal to] 1 isolate (isolation prevalence) and the number of patients with pulmonary disease (disease prevalence), divided by the population, according to the official census of Catalonia (https://www.
In the currently applicable Regulation of the Council of Ministers of June 30, 2009 [7] on occupational diseases, chronic obstructive pulmonary disease is included in the list of occupational diseases in point 5.
Chronic Obstructive Airways Disease or Chronic Obstructive Pulmonary Disease is acknowledged by the WHO as the fourth commonest cause of death worldwide.
The last two decades have seen an increase in the incidence of chronic obstructive pulmonary disease (COPD), making it one of the major health problems faced today1,2.
In May, the National Heart, Lung and Blood Institute released its first-ever national action plan for the country's third leading cause of death: chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease which is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases.